Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report
Introduction: We present a case of capsular block syndrome that occurred after intravitreal injection of ranibizumab in a patient with age-related macular degeneration, which has not been reported in the literature. Case Presentation: A 78-year-old male presented with decreased visual acuity in the...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2024-03-01
|
Series: | Case Reports in Ophthalmology |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/537755 |
_version_ | 1797214601065005056 |
---|---|
author | Jae Suk Kim |
author_facet | Jae Suk Kim |
author_sort | Jae Suk Kim |
collection | DOAJ |
description | Introduction: We present a case of capsular block syndrome that occurred after intravitreal injection of ranibizumab in a patient with age-related macular degeneration, which has not been reported in the literature. Case Presentation: A 78-year-old male presented with decreased visual acuity in the right eye. Slit-lamp examination findings were unremarkable; however, AMD was diagnosed based on fundus examination, fluorescein angiography, and optical coherence tomography (OCT). Subsequently, the patient was administered an intravitreal injection of ranibizumab. A slit-lamp examination revealed residual cortical material, numerous inflammatory cells, and posterior capsular distension 1 week after the injection. OCT showed an adhesion of the intraocular lens to the continuous curvilinear capsulorhexis site. The patient’s vision improved following Nd:YAG laser posterior capsulotomy. Conclusion: Meticulous cortical removal is crucial during phacoemulsification to prevent capsular block syndrome. In patients with a history of cataract surgery, verifying the absence of residual cortical material before administering an intravitreal injection of ranibizumab is important. |
first_indexed | 2024-04-24T11:16:46Z |
format | Article |
id | doaj.art-16446ab9ddfd4ade96f42099979eaebf |
institution | Directory Open Access Journal |
issn | 1663-2699 |
language | English |
last_indexed | 2024-04-24T11:16:46Z |
publishDate | 2024-03-01 |
publisher | Karger Publishers |
record_format | Article |
series | Case Reports in Ophthalmology |
spelling | doaj.art-16446ab9ddfd4ade96f42099979eaebf2024-04-11T06:33:40ZengKarger PublishersCase Reports in Ophthalmology1663-26992024-03-0115119620110.1159/000537755537755Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case ReportJae Suk Kim0Department of Ophthalmology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Republic of KoreaIntroduction: We present a case of capsular block syndrome that occurred after intravitreal injection of ranibizumab in a patient with age-related macular degeneration, which has not been reported in the literature. Case Presentation: A 78-year-old male presented with decreased visual acuity in the right eye. Slit-lamp examination findings were unremarkable; however, AMD was diagnosed based on fundus examination, fluorescein angiography, and optical coherence tomography (OCT). Subsequently, the patient was administered an intravitreal injection of ranibizumab. A slit-lamp examination revealed residual cortical material, numerous inflammatory cells, and posterior capsular distension 1 week after the injection. OCT showed an adhesion of the intraocular lens to the continuous curvilinear capsulorhexis site. The patient’s vision improved following Nd:YAG laser posterior capsulotomy. Conclusion: Meticulous cortical removal is crucial during phacoemulsification to prevent capsular block syndrome. In patients with a history of cataract surgery, verifying the absence of residual cortical material before administering an intravitreal injection of ranibizumab is important.https://beta.karger.com/Article/FullText/537755capsular block syndromeintravitreal injectionranibizumab |
spellingShingle | Jae Suk Kim Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report Case Reports in Ophthalmology capsular block syndrome intravitreal injection ranibizumab |
title | Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report |
title_full | Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report |
title_fullStr | Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report |
title_full_unstemmed | Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report |
title_short | Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report |
title_sort | capsular block syndrome after an intravitreal injection of ranibizumab a case report |
topic | capsular block syndrome intravitreal injection ranibizumab |
url | https://beta.karger.com/Article/FullText/537755 |
work_keys_str_mv | AT jaesukkim capsularblocksyndromeafteranintravitrealinjectionofranibizumabacasereport |